Financial Statements and Related Announcement::First Quarter Results

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PH US$200M4.5%210802 - XS1456577334 - 4N4B
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
Financial Statements and Related Announcement
Date &Time of Broadcast
13-Aug-2019 21:47:38
Status
New
Announcement Sub Title
First Quarter Results
Announcement Reference
SG190813OTHRQ3DQ
Submitted By (Co./ Ind. Name)
Glenmark Pharmaceuticals Ltd
Designation
Company Secretary & Compliance Officer
Effective Date and Time of the event
13/08/2019 00:00:00
Description (Please provide a detailed description of the event in the box below - Refer to the Online help for the format)
Sub: Outcome of the Board Meeting August 13, 2019

We wish to inform you that Board has today at its meeting approved the Unaudited Financial Results for the First Quarter ended June 30, 2019.

The said meeting of the Board commenced at 2.00 p.m. and concluded at 6.30 p.m.

The copy of the said results together with Management Discussion & Analysis, Press Release and Limited Review Report of the Auditors is enclosed herewith.

These are also being made available on the website of the Company at www.glenmarkpharma.com.

You are requested to take the same on record.

Additional Details

For Financial Period Ended
30/06/2019

Attachments

SGX_Result_300619.pdf
Total size =4430K